Clinical Trial Update: Efficacy and Safety of Yangxue Qingnao Pills in the Treatment of Mild to Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the efficacy and safety of Yangxue Qingnao Pills in mild to moderate Alzheimer's disease is in progress, with status not disclos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Yangxue Qingnao Pills

Snippet

Sponsor: Dongzhimen Hospital, Beijing | Conditions: Alzheimer Disease, Yangxue Qingnao Pills | Phase 2 | Status: UNKNOWN